Global Cancer Technology, Inc. — Regulation A 1-A/A
Global Cancer Technology, Inc. of SAN DIEGO, CA filed a Regulation A 1-A/A with the SEC on 2018-11-07. Aggregate offering: $5.5M (Tier 2). Industry: Other.
Offering
- Filed: 2018-11-07
- Form: 1-A/A
- Accession: 0001683168-18-003280
- Tier: Tier 2
- Total aggregate offering: $5.5M
- Issuer portion: $4.0M
- Selling securityholders: $1.5M
- Price per security: $3.0000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Ankit Consulting Inc.
- Jurisdictions: 52 states/territories
Issuer
- CIK: 0001743261
- Organized in: NV
- Incorporated: 2017
- Address: 16776 BERNARDO CENTER DRIVE, SAN DIEGO, CA, 92128
- Phone: 619-818-2411
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $33K
- Cash & equivalents: $32K
- Total liabilities: $323K
- Stockholder equity: $-289K
- Net income: $-186K
People (1)
| Name | Role | Location |
|---|
| Ronald N. Vance | Signer | SAN DIEGO, CA |
Other Reg A filings by this issuer (9)
More